News
Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results ...
Royalty revenue was $1,378 million in the first six months of 2025 compared to $1,111 million in the first six months of 2024, an increase of $267 million, or 24%. The increase in royalties was driven ...
August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025 Highlights Epcoritamab advancing to earlier lines of therapy with the submission of a sBLA to the FDA for epco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback